ARIAD Pharma (ARIA) Ticks Higher Following Preliminary Ponatinib Phase 2 Data
Go back to ARIAD Pharma (ARIA) Ticks Higher Following Preliminary Ponatinib Phase 2 Data| Ariad Pharmaceuticals, Inc. (NYSE: ARIA) | Delayed: 25.41 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.41 | 52 Week High | $14.34 | |||
| Open | $25.41 | 52 Week Low | $4.37 | |||
| Day High | $25.41 | P/E | N/A | |||
| Day Low | $25.41 | EPS | $-1.45 | |||
| Volume | 1,380 | |||||
